FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine and pharmaceutics and deals with inhibitors of Mycobacterium tuberculosis growth, representing (+) and (-) -enantiomers of usnic acid derivatives, which contain thiazole cycle.
EFFECT: inhibitors possess high bactericidal activity.
2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FURILIDENE FURANONE DERIVATIVES OF USNIC ACID AS NEW ANTITUBERCULOSIS AGENTS | 2013 |
|
RU2533707C1 |
| PREPARING QUATERNISED USNIC ACID DERIVATIVES AND THEIR BIOLOGICAL PROPERTIES | 2012 |
|
RU2477127C1 |
| 2-ACETYL-6-(2-(2-(4-BROMBENZYLIDENE)HYDRAZINYL)THIAZOL-4-YL)-3,7,9-TRIHYDROXY-8,9B-DIMETHYLDIOBENZO[B,D]FURAN-1(9BH)-OH, WITH INHIBITING ACTION ON HUMEN TYROSYL-DNA-PHOSPHODIESTERASE 1 | 2016 |
|
RU2627764C1 |
| HYDRAZINE THIAZOLE DERIVATIVES OF USNIC ACID WITH INHIBITORY ACTION TOWARDS HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME | 2015 |
|
RU2612256C1 |
| AGENT FOR INHIBITING HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME | 2015 |
|
RU2605329C1 |
| SILVER SALTS OF 1-ARYL-4,4,4-TRIFLUOROBUTANE-1,3-DIONES, EXHIBITING TUBERCULOSTATIC ACTIVITY | 2023 |
|
RU2817114C1 |
| ANTITUBERCULOUS THERAPEUTIC AGENT: COMPOSITION OF IMIDAZO[1,2-b]TETRAZINE AND PYRAZINAMIDE | 2013 |
|
RU2545458C2 |
| USE OF 3-ARYL-6H-SPIRO[BENZO[b]FURO[3',4':2,3]PYRROLO[1,2-d][1,4]OXAZINE-5,3'-INDOLINE]-1,2,2',6-TETRAONES AS AGENTS WITH ANTI-TUBERCULOSIS ACTIVITY | 2024 |
|
RU2831345C1 |
| NOVEL 5-MODIFIED PYRIMIDINE NUCLEOSIDES - Mycobacterium tuberculosis GROWTH INHIBITORS | 2013 |
|
RU2517173C1 |
| QUATERNARY AMMONIUM DERIVATIVES OF 2-AMINOTHIOPHEN-3-CARBOXYLATES HAVING ANTI-TUBERCULOSIS ACTIVITY | 2016 |
|
RU2629369C1 |
